We Design, Develop and Deploy Innovative Technology
Oue Science and Technology, Research and Development - R&D is focused on Healthcare, Life Sciences, Pharmaceuticals and Biopharmaceuticals
We design, develop, integrate, and deploy technology that help Healthcare Providers and Scientists and organizations in Life Sciences. Our ultimate goal is to develop innovative technology that help save lives. We adhere to the U.S. Food and Drug Administration's (FDA's) established guidelines and regulations.
Healthcare changes dramatically because of technological developments, from Anesthetics and Antibiotics to Magnetic Resonance Imaging - MRI scanners and Radiotherapy. Future technological innovation is going to keep transforming Healthcare, yet while technologies (new drugs and treatments, new devices, new social media support for Healthcare, etc) will drive innovation, human factors will remain one of the stable limitations of breakthroughs.
Healthcare’s Big Data market is expected to reach nearly $70 billion by 2025, according to Bain, a consultancy firm. As the collection of health data continues to accelerate, its applications become more widespread, and its potential for improving treatment options and patient outcomes skyrockets. The biggest barrier, however, has been a lack of interoperability: one Healthcare organization’s data is not easily transferred to (and easily processed by) another organization. Covid-19 underscored that problem further.
Interoperability took a large step forward in November 2020, when Google Cloud launched its Healthcare interoperability readiness program. Aimed at helping payers, providers, and other organizations prepare for the federal government’s interoperability regulations, it gives program participants access to data templates, app blueprints, security tools, and implementation guidelines. If Healthcare organizations can get on the same page, the potential of the industry’s big data could quickly turn kinetic.
In recent years, patients are expecting more targeted, effective and personalized therapies and New Science requires technology to become an integral part of the patient treatment. In addition, agility and responsiveness are more critical for Life Sciences companies than ever before. For all the tremendous success with the vaccine development, the COVID-19 pandemic has brought new complexity to supply chain and patient engagement models. The industry needs to scale its digital capabilities to address fluctuations in demand and improve resilience across its core operations.
In order to do so, Life Sciences CIOs have the opportunity to re-imagine their technology architectures and extend their ecosystem of partners to disrupt the way they deliver improved outcomes for patients.
Our Life Sciences technology practice helps navigate this ever changing technology landscape by identifying opportunities for significant capability advances with our enterprise advisory, platform, cloud, data and analytics services.